Guideline on specific adverse reaction follow-up questionnaires (Specific AR FUQ)
Submitted by Anonymous (not verified) on 6 December 2023 - 9:40
Guideline on specific adverse reaction follow-up questionnaires (Specific AR FUQ)
Proposed invented name(s) request form for veterinary medicinal products
Submitted by Anonymous (not verified) on 6 December 2023 - 7:53
Proposed invented name(s) request form for veterinary medicinal products
Quality Review of Documents (QRD) working group plenary meeting dates
Submitted by Anonymous (not verified) on 5 December 2023 - 15:18
Quality Review of Documents (QRD) working group plenary meeting dates
Norditropin (somatropin) supply shortage
Submitted by Anonymous (not verified) on 5 December 2023 - 15:06
Norditropin (somatropin) supply shortage
CTIS newsflash – 24 November 2023
Submitted by Anonymous (not verified) on 5 December 2023 - 14:25
CTIS newsflash – 24 November 2023
Agenda of the CVMP meeting 5-7 December 2023
Submitted by Anonymous (not verified) on 5 December 2023 - 13:01
Agenda of the CVMP meeting 5-7 December 2023
Orphan designation: Dabrafenib mesylate Treatment of glioma, 09/12/2020 Positive
Submitted by Anonymous (not verified) on 5 December 2023 - 11:00
Orphan designation: Dabrafenib mesylate Treatment of glioma, 09/12/2020 Positive
Second bilateral meeting between European Medicines Agency and Vaccines Europe, European Medicines Agency, Amsterdam, the Netherlands, 27 November 2023
Submitted by Anonymous (not verified) on 5 December 2023 - 11:00
Second bilateral meeting between European Medicines Agency and Vaccines Europe, European Medicines Agency, Amsterdam, the Netherlands, 27 November 2023
Relaunched EMA website now live
Submitted by Anonymous (not verified) on 5 December 2023 - 9:00
Relaunched EMA website now live
Enalapril : List of nationally authorised medicinal products - PSUSA/00001211/202303
Submitted by Anonymous (not verified) on 4 December 2023 - 16:50
Enalapril : List of nationally authorised medicinal products - PSUSA/00001211/202303